Maximizing the Hidden Potential of the Human Life Span

CARNYX Technology

Carnyx is a team of expert scientists, drug developers and commercial strategists with a proven record of taking new therapies to patients.

Our goal is to understand, validate, and obtain fast-track regulatory approval for application of game-changing novel therapeutics in human disturbances.

Carnyx’s molecular assets are designed to improve sleep and delay and reverse retinitis pigmentosa.

Retinitis Pigmentosa

Retinitis Pigmentosa affects around 1.5 million people worldwide and is a leading cause of inherited blindness caused by progressive retinal degeneration. Moreover, with 1 in 3000 children now being diagnosed with retinitis pigmentosa with very limited therapeutic options available. There are currently limited effective treatments available for the majority of patients.

Our gene-independent localized therapy, CNYX-001, administered by eye-drop, has shown impressive biological effects and has significant advantages in a disease with multiple genetic causes.

Longevity

True longevity integrates both the quantity of years lived and the quality within them: creating a life marked not just by duration, but by vitality, independence, and joy. Carnyx technologies are designed to extend both the chronological age, but also improve overall physicality by reducing inflammation, protecting against DNA damage, and facilitating cellular waste clearance.

Sleep

Sleep deficiency greatly affects health outcomes by increasing the risk of chronic diseases such as type 2 diabetes, obesity, heart disease and high blood pressure. It negatively impacts several key quality of life measures such as problem solving, mood, behaviour and immune system response. Improved sleep duration and regularity are both important for longevity and poor sleep can increase the risk of mortality.

Pipeline

  
        Program
        Indication
        Administration Route
        IND enabling
        Phase I
        Phase II
      
        CNYX-001
        Retinitis Pigmentosa
        Eye drop
        
        CNYX-002
        Sleep
        Oral